Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Regadenoson pharmacologic stress for myocardial perfusion imaging: a three-way comparison between regadenoson administered at peak exercise, during walk recovery, or no-exercise.
Thompson RC, Patil H, Thompson EC, Thomas GS, Al-Amoodi M, Kennedy KF, Bybee KA, Iain McGhie A, O'Keefe JH Jr, Oakes L, Bateman TM. Thompson RC, et al. Among authors: thomas gs. J Nucl Cardiol. 2013 Apr;20(2):214-21; quiz 222-6. doi: 10.1007/s12350-012-9660-4. Epub 2012 Dec 12. J Nucl Cardiol. 2013. PMID: 23233371 Clinical Trial.
The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging.
Thomas GS, Thompson RC, Miyamoto MI, Ip TK, Rice DL, Milikien D, Lieu HD, Mathur VS. Thomas GS, et al. J Nucl Cardiol. 2009 Jan-Feb;16(1):63-72. doi: 10.1007/s12350-008-9001-9. Epub 2009 Jan 20. J Nucl Cardiol. 2009. PMID: 19152130 Clinical Trial.
The EXERRT trial: "EXErcise to Regadenoson in Recovery Trial": A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol.
Thomas GS, Cullom SJ, Kitt TM, Feaheny KM, Ananthasubramaniam K, Gropler RJ, Jain D, Thompson RC. Thomas GS, et al. J Nucl Cardiol. 2017 Jun;24(3):788-802. doi: 10.1007/s12350-017-0813-3. Epub 2017 Feb 21. J Nucl Cardiol. 2017. PMID: 28224449 Free PMC article. Clinical Trial.
The EXXERT Study.
Thompson RC, Thomas GS. Thompson RC, et al. Among authors: thomas gs. J Nucl Cardiol. 2017 Oct;24(5):1800-1802. doi: 10.1007/s12350-017-0903-2. Epub 2017 May 23. J Nucl Cardiol. 2017. PMID: 28537038 Clinical Trial. No abstract available.
Is coronary calcium scoring too late? Total body arterial calcium burden in patients without known CAD and normal MPI.
Allam AHA, Thompson RC, Eskander MA, Mandour Ali MA, Sadek A, Rowan CJ, Sutherland ML, Sutherland JD, Frohlich B, Michalik DE; HORUS research team; Finch CE, Narula J, Thomas GS, Samuel Wann L. Allam AHA, et al. Among authors: thomas gs. J Nucl Cardiol. 2018 Dec;25(6):1990-1998. doi: 10.1007/s12350-017-0925-9. Epub 2017 May 25. J Nucl Cardiol. 2018. PMID: 28547671
154 results